Evolution of the inflammatory profile and redox status in COVID-19 patients: Possible therapeutic targets?
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: COV20_00491
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
Eduardo Tamayo GómezResearch Location
SpainLead Research Institution
Hospital Clínico Universitario de ValladolidResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
Innovation
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The risk of patients with COVID19 increases with age, as does the redox status and the inflammatory component. In relation to the hypothesis of this work is that in COVID19 patients there is an inflammatory profile associated with the severity of the disease that evolves depending on the ability of the patient to stabilize its redox status. The objectives of this work are to carry out a clinical biological and molecular characterization of the Covid19 disease as well as to establish one of innovative therapeutic targets and prognostic biomarkers of clinical activity and even death that can considerably reduce the mortality trend that our country currently suffers.